Certains contenus de cette application ne sont pas disponibles pour le moment.
Si cette situation persiste, veuillez nous contacter àObservations et contact
1. (IN201617042413) ANTIBODIES DIRECTED AGAINST CD127

Office : Inde
Numéro de la demande : 201617042413 Date de la demande : 12.12.2016
Numéro de publication : 201617042413 Date de publication : 24.03.2017
Type de publication : A
Référence PCT: Numéro de la demande :PCTEP2015062993 ; Numéro de publication :WO2015189302 Cliquer pour voir les données
CIB :
C07K 16/28
A61K 39/00
C CHIMIE; MÉTALLURGIE
07
CHIMIE ORGANIQUE
K
PEPTIDES
16
Immunoglobulines, p.ex. anticorps monoclonaux ou polyclonaux
18
contre du matériel provenant d'animaux ou d'humains
28
contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire
A NÉCESSITÉS COURANTES DE LA VIE
61
SCIENCES MÉDICALE OU VÉTÉRINAIRE; HYGIÈNE
K
PRÉPARATIONS À USAGE MÉDICAL, DENTAIRE OU POUR LA TOILETTE
39
Préparations médicinales contenant des antigènes ou des anticorps
Déposants : OSE IMMUNOTHERAPEUTICS
Inventeurs : POIRIER Nicolas
MARY Caroline
VANHOVE Bernard
Données relatives à la priorité : 15305078.6 23.01.2015 EP
62/010117 10.06.2014 US
Titre : (EN) ANTIBODIES DIRECTED AGAINST CD127
Abrégé :
(EN) The invention relates to antibodies directed against CD127 the alpha chain of the interleukin 7 (IL-7) receptor IL-7R) and which have antagonist properties for IL-7-IL-7R interaction may present cytotoxic activity against CD127 positive cells but do not increase the maturation of dendritic cells (DCs) induced by TSLP a cytokine also using CD127 as part of its receptor. Alternatively or in addition these antibodies do not induce the internalization of CD127 and/or inhibit the IL7 induced internalization of CD127. According to another aspect of the invention antibodies are provided which recognize a human CD127 epitope comprising sequences from the 2b site of CD127 in particular the epitope comprising comprises the human CD127 sequences of domain D1 and of the 2b site of CD127 in particular the epitope comprises at least one sequence from D1 comprising SEQ ID No: 115 (in particular comprising SEQ ID No: 10) and/or SEQ ID No: 111 and / or a sequence from the 2b site comprising the sequence of SEQ ID No: 116 and optionally also comprises SEQ ID No: 117 (in particular comprises SEQ ID No: 111).The antibodies of the invention are suitable for use inorder to remedy to a condition diagnosed in a human patient which results from pathogenesis related to lymphopoiesis when IL 7 signalling pathways provide contribution to said pathogenesis especially when an increase in the maturation more precisely the upregulation of costimulatory molecules of dendritic cells is undesirable.
Également publié sous:
UAa201613258SG11201610036PCA2950823AU2015273532EP3155014KR1020170019417
US20170129959IL249449CN106715471VN52585MYPI 2016002094PH1/2016/502445
JP2017522903TH171839BR112016028755TN2016000528EA201692460RU2016151265
CR20160576WO/2015/189302